We now know that ovarian cancer is not a single disease, but a variety of cancers that share a location in or near the ovaries, and that many of these cancers arise from cells outside the ovary. Up to 80% of ovarian can-cer deaths are caused by high-grade serous ovarian cancer (HGSC), but this mostly arises from cells of the fallopian tube spreading to the ovary.
75%Ovarian cancer is rarely diagnosed in the early stages and around 75% of patients present with advanced cancer at diagnosis
35–40%Survival has little improved over the last 20 years and only 35–40% are likely to survive for five years
TOP 5Ovarian cancer is the fifth most common cause of cancer deaths in Western women
100,000Globally an estimated 100,000 women die each year from recurrent ovarian cancer
Ovarian cancer research at Garvan
Professor Bowtell leads the Ovarian Cancer Program at the Garvan Institute and also holds a joint appointment at the Peter MacCallum Cancer Centre. He is a world-leading researcher in ovarian cancer and his team have contributed substantially to an improved understanding of the diversity and biology of ovarian cancer. Professor David Bowtell is also leader of the Australian Ovarian Cancer Study, one of the largest and most sophisticated studies of ovarian cancer in the world.